Immune Cell Profiles and Predictive Modeling in Osteoporotic Vertebral Fractures Using XGBoost Machine Learning Algorithms

Overview

Journal BioData Min

Publisher Biomed Central

Date 2025 Feb 5

PMID 39905521

Authors

Yi-Chou Chen

Hui-Chen Su

Shih-Ming Huang

Ching-Hsiao Yu

Jen-Huei Chang

Yi-Lin Chiu

Affiliations

Soon will be listed here.

Abstract

Background: Osteoporosis significantly increases the risk of vertebral fractures, particularly among postmenopausal women, decreasing their quality of life. These fractures, often undiagnosed, can lead to severe health consequences and are influenced by bone mineral density and abnormal loads. Management strategies range from non-surgical interventions to surgical treatments. Moreover, the interaction between immune cells and bone cells plays a crucial role in bone repair processes, highlighting the importance of osteoimmunology in understanding and treating bone pathologies.

Methods: This study aims to investigate the xCell signature-based immune cell profiles in osteoporotic patients with and without vertebral fractures, utilizing advanced predictive modeling through the XGBoost algorithm.

Results: Our findings reveal an increased presence of CD4 + naïve T cells and central memory T cells in VF patients, indicating distinct adaptive immune responses. The XGBoost model identified Th1 cells, CD4 memory T cells, and hematopoietic stem cells as key predictors of VF. Notably, VF patients exhibited a reduction in Th1 cells and an enrichment of Th17 cells, which promote osteoclastogenesis and bone resorption. Gene expression analysis further highlighted an upregulation of osteoclast-related genes and a downregulation of osteoblast-related genes in VF patients, emphasizing the disrupted balance between bone formation and resorption. These findings underscore the critical role of immune cells in the pathogenesis of osteoporotic fractures and highlight the potential of XGBoost in identifying key biomarkers and therapeutic targets for mitigating fracture risk in osteoporotic patients.

References

Feng W, Liu H, Luo T, Liu D, Du J, Sun J . Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-κB, ERK and JNK signaling pathways. Sci Rep. 2017; 7:41411. PMC: 5269740. DOI: 10.1038/srep41411. View

Aurora R, Silva M . T cells heal bone fractures with help from the gut microbiome. J Clin Invest. 2023; 133(8). PMC: 10104886. DOI: 10.1172/JCI167311. View

Weber A, Boris Chan P, Wen C . Do immune cells lead the way in subchondral bone disturbance in osteoarthritis?. Prog Biophys Mol Biol. 2017; 148:21-31. DOI: 10.1016/j.pbiomolbio.2017.12.004. View

Zhao R . Immune regulation of bone loss by Th17 cells in oestrogen-deficient osteoporosis. Eur J Clin Invest. 2013; 43(11):1195-202. DOI: 10.1111/eci.12158. View

Majchrzak K, Nelson M, Bowers J, Bailey S, Wyatt M, Wrangle J . β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity. JCI Insight. 2017; 2(8). PMC: 5396523. DOI: 10.1172/jci.insight.90547. View

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y . Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006; 203(12):2673-82. PMC: 2118166. DOI: 10.1084/jem.20061775. View

Riggs B, Melton 3rd L, OFallon W . Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone. 1996; 18(3 Suppl):197S-201S. DOI: 10.1016/8756-3282(95)00502-1. View

Ni Y, Li H, Zhang Y, Zhang H, Pan Y, Ma J . Association of IL-6 G-174C polymorphism with bone mineral density. J Bone Miner Metab. 2013; 32(2):167-73. DOI: 10.1007/s00774-013-0477-2. View

Chen E, Tan C, Kou Y, Duan Q, Wang Z, Meirelles G . Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013; 14:128. PMC: 3637064. DOI: 10.1186/1471-2105-14-128. View

10.

Eastell R, Cedel S, Wahner H, Riggs B, Melton 3rd L . Classification of vertebral fractures. J Bone Miner Res. 1991; 6(3):207-15. DOI: 10.1002/jbmr.5650060302. View

11.

Boyce B . Advances in the regulation of osteoclasts and osteoclast functions. J Dent Res. 2013; 92(10):860-7. PMC: 3775372. DOI: 10.1177/0022034513500306. View

12.

Dar H, Perrien D, Pal S, Stoica A, Uppuganti S, Nyman J . Callus γδ T cells and microbe-induced intestinal Th17 cells improve fracture healing in mice. J Clin Invest. 2023; 133(8). PMC: 10104897. DOI: 10.1172/JCI166577. View

13.

Ono T, Okamoto K, Nakashima T, Nitta T, Hori S, Iwakura Y . IL-17-producing γδ T cells enhance bone regeneration. Nat Commun. 2016; 7:10928. PMC: 4792964. DOI: 10.1038/ncomms10928. View

14.

Jiang G, Luo J, Pollintine P, Dolan P, Adams M, Eastell R . Vertebral fractures in the elderly may not always be "osteoporotic". Bone. 2010; 47(1):111-6. DOI: 10.1016/j.bone.2010.03.019. View

15.

Giampietro P, McCarty C, Mukesh B, McKiernan F, Wilson D, Shuldiner A . The role of cigarette smoking and statins in the development of postmenopausal osteoporosis: a pilot study utilizing the Marshfield Clinic Personalized Medicine Cohort. Osteoporos Int. 2009; 21(3):467-77. DOI: 10.1007/s00198-009-0981-3. View

16.

Yuan F, Li X, Lu W, Zhao Y, Li C, Li J . Type 17 T-helper cells might be a promising therapeutic target for osteoporosis. Mol Biol Rep. 2011; 39(1):771-4. DOI: 10.1007/s11033-011-0797-z. View

17.

Haffner-Luntzer M, Weber B, Morioka K, Lackner I, Fischer V, Bahney C . Altered early immune response after fracture and traumatic brain injury. Front Immunol. 2023; 14:1074207. PMC: 9905106. DOI: 10.3389/fimmu.2023.1074207. View

18.

Baht G, Vi L, Alman B . The Role of the Immune Cells in Fracture Healing. Curr Osteoporos Rep. 2018; 16(2):138-145. PMC: 5866272. DOI: 10.1007/s11914-018-0423-2. View

19.

Brustle A, Heink S, Huber M, Rosenplanter C, Stadelmann C, Yu P . The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol. 2007; 8(9):958-66. DOI: 10.1038/ni1500. View

20.

Kryczek I, Zhao E, Liu Y, Wang Y, Vatan L, Szeliga W . Human TH17 cells are long-lived effector memory cells. Sci Transl Med. 2011; 3(104):104ra100. PMC: 3345568. DOI: 10.1126/scitranslmed.3002949. View